Jazz Pharmaceuticals plc — Director's Dealing 2014

May 7, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-05-05

Reporting Person: Young Matthew P. (SVP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-05	Ordinary Shares	F	1127	$141.98	Disposed	15630	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: Includes 257 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 29, 2013.